3D Bio-Tissues

Ivy Farm Gyoza dish

© Ivy Farm

Cultivated Meat

BSF Enterprise and Ivy Farm Partner to Produce Cultivated Meat in China

Two UK firms, BSF Enterprise, owner of the UK clinical and cell ag company 3D Bio-Tissues (3DBT), and the cultivated meat company Ivy Farm Technologies, have partnered to fundraise, produce, and scale cultivated meat in China. BSF Enterprise (LSE: BSFA) (OTCQB: BSFAF) announced that the commercial agreement involves securing investment to help Ivy Farm enter the Chinese market and find key manufacturers to develop various cultivated meat products. Last year, BSF Enterprise formed a separate entity (BSF HK) and opened an office in Hong Kong to develop a distribution and partner network to commercialize its products and launch cultivated meat in the country. China consumes over 100 million tons of meat (with pork as the preferred meat), which is more than a quarter of global meat consumption, representing a …

more

Topics:

3DBT cultivated meat steak

Image courtesy of 3D Bio-Tissues

Cultivated Meat

BSF & CellRev Form New Venture ‘Cultivated Meat Technologies Limited’ to Mass-Produce Cultivated Meat

Two UK firms, BSF Enterprise, owner of the UK clinical and cell ag company 3D Bio-Tissues (3DBT), and bioprocessing company CellRev, will combine their resources and expertise to launch a new company focused on the mass production of cultivated meat. BSF Enterprise (LSE: BSFA), (OTCQB: BSFAF), announced the exclusive joint venture, revealing they had already entered a Terms Sheet and expect to form the biotech in the coming months. The news follows the UK’s government recently announced a £2 billion plan to seize the potential of biotechnology. The new company, Cultivated Meat Technologies Limited (CMT), will create technology solutions to successfully scale the production of cell-based meat at lower costs to bring products to the market.  “We have observed the early success of 3D Bio tissues with …

more

Topics:

Ivy Farm and Finnebrogue partner to bring cultivated Wagyu beef to the UK  

Image courtesy of Ivy Farm
Cultivated, Cell-Cultured & Biotechnology

Biotech Firms Awarded €1.2M for Creating Animal-Free Cell Culture Media to Make Cultivated Meat a “Commercial Reality”

Commercializing cell-based products such as cultivated meat remains challenging due to the substantial costs and ethical implications of fetal bovine serum. To find solutions, EIT Food, the world’s largest and most dynamic food innovation community, and the Good Food Institute (GFI) Europe launched the Cultivated Meat Innovation Challenge to develop a more affordable and efficient animal-free cell culture media. The winners, UK biotech company 3D Bio-Tissues and Israeli biotech startup BioBetter have received €1.2 million from EIT Food. With the funds, the companies will continue their R&D efforts in developing lower-cost alternatives to bovine serum. Moreover, they will produce cultivated meat products using their innovations.  Dr. Adam M. Adamek, director of innovation at EIT Food, said: “The cost of cell-culture media is a significant barrier to scaling …

more

3DBT cell culture media city mix

© 3D Bio-Tissues

Company News

3D Bio-Tissues Opens Office in Hong Kong to Commercialise its Flagship Cell Media in China

UK-based clinical and cell ag company 3D Bio-Tissues (3DBT) has recently expanded internationally with a new office in Hong Kong to introduce its flagship cell-boosting media supplement, City-Mix, to the Chinese cultivated meat market.  3DBT will also target the Chinese biotech industry, especially gene therapy, stem cells, regenerative medicine, Life Sciences companies, and academia. The company already started hiring R&D experts and sales and marketing specialists to develop a go-to-market strategy, build distribution networks, and establish manufacturing partners in China.  The announcement was made by the biotech investor BSF Enterprise (LSE: BSFA), which owns 3DBT. Recently, BSF raised £2.9 million to provide working capital for its subsidiary to accelerate its progress and develop systems to expedite the production and supply of its media growth and target manufacturers.  Commercial presence 3DBT, a Newcastle University …

more

3DBT's co-founders tasting successful developed 100% meat cultivated pork fillet

Image courtesy of 3D Bio-Tissues
Company News

3DBT Makes Progress Growing 100% Meat Cultivated Pork Fillet & New Strips with Animal-Free Medium

Biotech investor BSF Enterprise has announced that its wholly-owned subsidiary, 3D Bio-Tissues (3DBT), a biotech company focused on developing bio-equivalent tissues cell ag and for clinical use, has been progressing positively in developing its cultivated meat products. 3DBT is producing and will display its 100% meat cultivated pork fillet and other new 100% meat strips of cultivated pork before the end of Q3, said BSF on social media. At the end of March, BSF raised £2.9 million to provide working capital for its subsidiary to accelerate its progress and increase its capacity to produce cultivated meat and leather using its animal-free media platform, City-Mix. It creates structured, functional, and scalable tissues without scaffolding as structural support for cell attachment. In November, the UK-based biotech company announced the successful development of cultivated meat …

more

Topics:

3DBT cultivated meat steak

Image courtesy of 3D Bio-Tissues

Cultivated, Cell-Cultured & Biotechnology

3DBT Receives £2.9M in Capital To Expedite Production of Cultivated Meat and Leather

London’s BSF Enterprise, a biotech company focused on lab-grown meat that wholly owns clinical and cellular agriculture company 3D Bio-Tissues (3DBT), has raised £2.9 million via an oversubscribed placing at 17p/share, reports Vox Markets.  BSF will use the new investment to provide working capital for 3DBT to accelerate its progress and increase its capacity to produce cultivated meat and leather using its serum-free media platform, City-Mix. Serum-free media, City-Mix  Following its acquisition by BSF in May 2022, 3DBT said it was working to produce the UK’s first cultivated meat cut. Five months later, the biotech announced the successful development of three small cultivated meat prototypes using its tissue templating platform, City-Mix, which does not use scaffolding as structural support for cell attachment. In February, 3DBT announced it had …

more

3DBT cultivated meat steak

Image courtesy of 3D Bio-Tissues

Cultivated Meat

3DBT Says it Has Developed the First Truly 100% Cultivated Meat Steak. Here’s Why.

UK-based biotech company 3D Bio-Tissues (3DBT) announces it has successfully developed what it claims to be the “world’s first” 100% cultivated meat steak. Although Aleph Farms likely holds the industry’s milestone for the “world’s first” cultivated steak (let us know if we’re wrong); 3DBT argues that the difference with other companies is that its fillet was grown without plant-based scaffolds making it the world’s first “100% meat” cultivated steak.  “Some other companies have produced lab-grown meat using plant-based scaffolds to facilitate the development of muscle, fat, and connective tissue. These are classified as hybrid cultivated meat products,” responded George Esmond when vegconomist enquired about the “world’s first” claim. A moot point for the industry Are cultivated products, grown using plant-based ingredients, to be considered hybrid products? We have …

more

alternative protein market company Upside Foods serves a cultivated chicken burger

© UPSIDE Foods
Business Wire

Global Cultured Meat Markets Report – By 2040, a Projected 60% of Meat will be Created from Cells Grown Within Bioreactors and Sold Across Grocery Stores and Restaurants Worldwide

DUBLIN–(BUSINESS WIRE)–The “The Global Market for Cultured Meat – Market Size, Trends, Competitors, and Forecasts (2022)” report has been added to ResearchAndMarkets.com’s offering. By 2040, a projected 60% of the meat will be created from cells grown within bioreactors and sold across grocery stores and restaurants worldwide. The rise of the cultured meat market will be supported by the sustainability of the process, as well as the industry’s ability to provide “tailor-made nutrition” through its meat and seafood products. Recent surveys indicate that nearly 50% of the consumers do not have any reservations about cultured meat. Over the next 10 to 20 years, the cultured meat market is projected to act as a major disruptor to the conventional meat market. The number of startups focused …

more

3D Bio-Tissues team posing for a photo

3DBT's team © 3D Bio-Tissues

Investments & Acquisitions

3DBT to Produce “UK’s First Cultivated Meat” Within 12 Months Following BSF Acquisition

Biotech company 3D Bio-Tissues (3DBT) has been acquired by London’s BSF Enterprise for £1.25 million. 3DBT is working towards producing what it claims will be the UK’s first cultivated meat cut within the next year. The company, which is a spinoff from the University of Newcastle, has a focus on tissue engineering — its tissue templating platform can be used to produce cultivated meat and leather, along with human tissues. Additionally, 3DBT has developed an animal-free cell growth medium that can be used to produce cultivated muscle, fat, and skin tissue. Prior to the acquisition, the company received funding from Canada’s CULT Food Science, an investment platform with a focus on cultivated alt-protein products. Cultivated meat in the UK While cultivated meat research in the …

more

3D Bio-Tissues team posing for a photo

3DBT's team © 3D Bio-Tissues

Printed Technology

Canada’s CULT Food Science Corp Makes Strategic Investment into UK’s 3D Bio-Tissues Ltd

Canadian investment platform CULT Food Science Corp announces that it has made a strategic investment into UK firm 3D Bio-Tissues Limited (3DBT). The move comes as the platform – with an exclusive focus on clean, lab-grown food – increases its stakes across the field.  Based in the UK, 3DBT produces biological tissue material that can be used for cultivated meat, synthetic leather, and collagen production. A spin-off from Newcastle University,  3DBT’s patented technology also provides an alternative source of animal leather that is resilient to the global leather market’s supply chain and trade limitations. CULT Food’s investment in 3DBT furthers the platform’s exposure to cellular agriculture-focused intellectual property including innovative tissue templating and culture fluid technologies. CULT Food’s platform aims to advance the development of …

more